GABBI

Serial Number 98000746
Registration 7454083
700

Registration Progress

Application Filed
May 17, 2023
Under Examination
Approved for Publication
May 7, 2024
Published for Opposition
May 7, 2024
Registered
Jul 23, 2024

Trademark Image

GABBI

Basic Information

Serial Number
98000746
Registration Number
7454083
Filing Date
May 17, 2023
Registration Date
July 23, 2024
Published for Opposition
May 7, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 23, 2024
Registration
Registered
Classes
042 044

Rights Holder

Gabbi, Inc.

03
Address
10350 N Vancouver Way #1067
Portland, OR 97217

Ownership History

Gabbi, Inc.

Original Applicant
03
Portland, OR

Gabbi, Inc.

Owner at Publication
03
Portland, OR

Gabbi, Inc.

Original Registrant
03
Portland, OR

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
1730 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-23)
Due Date
July 23, 2030
Grace Period Ends
January 23, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Jul 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 3, 2024 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Apr 2, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 2, 2024 IUAA P USE AMENDMENT ACCEPTED Loading...
Mar 25, 2024 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Mar 25, 2024 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Mar 25, 2024 IUAF S USE AMENDMENT FILED Loading...
Mar 20, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 20, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 20, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 15, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing temporary use of non-downloadable computer software for assessing cancer risk and providing risk mitigation measures; providing temporary use of non-downloadable computer software for providing outreach, risk assessment, action plans, ongoing management, and a virtual care concierge for the purpose of early cancer detection; providing temporary use of non-downloadable computer software featuring a survey for identifying risk level in connection with cancer and proposing risk mitigation measures; providing temporary use of non-downloadable computer software for breast cancer risk assessment and mitigation; providing temporary use of non-downloadable computer software for the purpose of providing virtual healthcare concierge services via licensed medical professionals; providing temporary use of non-downloadable computer software for providing and reviewing breast cancer risk assessment scores, providing individual consultations, managing a treatment plan by ordering and reviewing diagnostic test results, ordering genetic testing, prescribing medication, providing referrals to specialists, managing breast health, following up with patients, providing patient education, collaborating with members of the medical team, and reviewing clinical documentation
First Use Anywhere: Jan 1, 2022
First Use in Commerce: Jan 1, 2022
Class 044
Medical evaluation of breast cancer risk assessment scores; medical evaluation of cancer risk; medical consultations; medical treatment, namely, managing patient treatment plans by ordering and reviewing diagnostic test results, ordering genetic testing, prescribing medication, providing referrals to specialists, managing breast health, following up with patients, providing patient education, collaborating with members of the medical team, and reviewing clinical documentation
First Use Anywhere: Jun 1, 2023
First Use in Commerce: Jun 1, 2023

Classification

International Classes
042 044